Non-muscle Invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Non-muscle Invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC [Phase 2]
A Phase 2 clinical trial of T3011 in patients with nonmuscle-invasive bladder cancer who are BCG-unresponsive or BCG-exposed and chemotherap…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC. [Phase 1, Phase 2]
This clinical trial explores a tumor immune biomarker-guided strategy to improve response to Bacillus Calmette-Guérin (BCG) therapy in high-…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Observational Clinical Study on High - Risk NMIBC Patients Choosing Trimodality Bladder - Sparing Therapy
An observational study conducted at Peking University First Hospital examines outcomes for patients with high-risk non-muscle invasive bladd…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing [NA]
This clinical trial update outlines an ongoing study evaluating whether a second transurethral resection is necessary in high-risk non-muscl…
-
CLINICAL_TRIALS withdrawal · 2025-06-16Clinical Trial Update: A Study to Evaluate Eciskafusp Alfa in Combination With Bacillus Calmette-guerin (BCG) in Participants With BCG-unresponsive High-risk Non-muscle Invasive Bladder Cancer (NMIBC) [Phase 1]
Phase 1 study evaluating Eciskafusp Alfa in combination with Bacillus Calmette-Guérin for BCG-unresponsive high-risk Non-muscle Invasive Bla…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating proliposomal intravesical paclitaxel for low-grade, Ta non-muscle invasive bladder cancer has completed with tr…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC [Phase 2]
Open-label Phase 2 trial to evaluate the safety and efficacy of NDV01 KIT for high-grade non-muscle-invasive bladder cancer, currently recru…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment [Phase 1, Phase 2]
Clinical trial update for a Phase 1/2 study evaluating the combination of Bacillus Calmette-Guérin (BCG) and Gemcitabine in patients with hi…
-
FDA approval · 2025-06-12FDA Approved: ZUSDURI — Original Application (UroGen Pharma, Inc)
FDA approves ZUSDURI (mitomycin) from UroGen Pharma under an original NDA, marking its first approval for use in bladder cancer.
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: BCG for Therapeutic Use Phase I Clinical Trial [Phase 1]
This Phase I study evaluated therapeutic Bacillus Calmette-Guérin for non-muscle invasive bladder cancer and has completed.
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer
An update on a Trop2-targeting NIR-II molecular probe intended to help guide identification of non-muscle-invasive bladder cancer; the trial…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: T-Control® Safety for Cytostatics Management [NA]
A clinical trial update announces a study evaluating T-Control for safety management of cytostatics in non-muscle-invasive bladder cancer, w…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)
Recruitment is ongoing for a multicenter prospective cohort study evaluating urinary microscopic residual disease as a method to monitor rec…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study [NA]
An open-label, single-arm Phase 2 trial is evaluating radiotherapy for BCG-unresponsive non-muscle-invasive bladder cancer with carcinoma in…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial [NA]
A randomized trial is investigating how anesthesia modality may influence oncologic outcomes in high-risk non-muscle invasive bladder cancer…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention [Phase 2]
Phase 2 clinical trial evaluating encapsulated rapamycin (eRapa) for prevention of non-muscle invasive bladder cancer is currently recruitin…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer
This registry-based clinical trial in France is evaluating the therapeutic management and follow-up of Non-Muscle-Invasive Bladder Cancer an…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER
AstraZeneca-sponsored BRA-BLADDER study evaluating bladder cancer in Brazil has completed, examining urothelial carcinoma across non-muscle …
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment [Phase 1]
This clinical trial update describes a Phase 1 study of combining irinotecan liposome with epirubicin in patients with recurrent non-muscle …
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer [NA]
A clinical trial is evaluating immediate chemotherapy after surgical resection for high-risk non-muscle-invasive bladder cancer and is curre…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer [NA]
This clinical trial update notes that a study evaluating bladder-sparing treatment strategies for large-volume non-muscle-invasive bladder c…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)
Clinical trial update for intravesical N-803 plus BCG in BCG-naive non-muscle invasive bladder cancer, with the study listed as active but n…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids [Phase 2]
A Phase 2 clinical trial is exploring instillation therapy guided by drug screens in patient-derived organoids for non-muscle-invasive bladd…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients [Phase 3]
A Phase 3 trial is evaluating the efficacy and safety of neoadjuvant intravesical Mitomycin C in high-risk non-muscle-invasive bladder cance…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC [Phase 1, Phase 2]
This is a clinical trial update for SHR-1501 alone or in combination with BCG or SHR-1316 in high-risk non-muscle invasive bladder cancer (N…